3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Breast Neoplasms
930
Neoplasms
708
Prostatic Neoplasms
490
Lung Neoplasms
398
Carcinoma, Non-Small-Cell Lung
359
Colorectal Neoplasms
357
Leukemia, Myeloid, Acute
290
Pancreatic Neoplasms
238
Brain Neoplasms
227
Neoplasm Metastasis
221
Multiple Myeloma
214
Carcinoma, Hepatocellular
199
Head and Neck Neoplasms
182
Glioblastoma
181
Precursor Cell Lymphoblastic Leukemia-Lymphoma
177
Melanoma
173
Ovarian Neoplasms
168
Squamous Cell Carcinoma of Head and Neck
160
Uterine Cervical Neoplasms
144
Rectal Neoplasms
144
Recurrence
142
Hematologic Neoplasms
134
Sarcoma
133
Triple Negative Breast Neoplasms
127
Stomach Neoplasms
127
Glioma
126
Carcinoma, Renal Cell
123
Colonic Neoplasms
113
Myelodysplastic Syndromes
112
Urinary Bladder Neoplasms
109
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gallbladder Cancer Unresectable
×
90 days
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled